Symbols

IGC

IGC Pharma·AMEX

--(--)

IGC Profile

Igc Pharma, Inc.

A biotech company that develops and commercializes cannabis-based therapies for various medical conditions

Industry

Pharmaceutical

Established Date

04/29/2005

Listing Date

02/27/2019

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.igcinc.us

Security Type

Common stock

Office address

10224 Falls Road, Potomac, Maryland 20854

Business

Introduction

IGC Pharma, Inc., a Maryland corporation, was established on April 29, 2005. The company is a clinical-stage biotechnology company focused on the development of novel therapies for neuropsychiatric and neurodegenerative diseases, primarily for Alzheimer's disease. Its lead drug candidate, IGC-AD 1, is in Phase 2 trials for Alzheimer's dementia agitation, while an artificial intelligence data platform for research support is also being developed.